Search

everythinglearnresearchcommunity

for

Search:↓

A baby's toe was severely damaged by a hair tourniquet, leading to bone and tendon damage, but improved after surgery and treatment.

Telogen effluvium is a common hair loss condition requiring careful diagnosis and treatment.

Telogen effluvium is a condition that causes temporary hair loss due to stress or shock to the body.

Tjalma Syndrome is a rare condition in people with lupus, causing fluid buildup and high CA-125 levels, but not due to tumors.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Early diagnosis, genetic testing, and personalized care are essential for managing tuberous sclerosis.

The tumescent technique makes hair micrografting more comfortable and efficient.

Hair shedding after childbirth can reveal a pre-existing condition of hair loss due to tight hairstyles.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Trichoscopy effectively diagnoses temporal triangular alopecia in children.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Hair-tourniquet syndrome can cause serious toe injuries in infants but can be treated if found early.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Telogen effluvium is a condition that causes temporary hair loss.

Intralesional triamcinolone acetonide is effective and safe for treating early to mid-stage traction alopecia.

Telogen effluvium is a type of hair loss where more hair than normal falls out after stress or illness.

TQC shows promise for better hair regrowth in treating hair loss.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Triangular temporal alopecia can occur in adults and should be correctly identified to prevent misdiagnosis.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

Successful outcomes depend on accurate diagnosis and strong doctor-patient relationships.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Hair-thread Tourniquet Syndrome, where hair or thread tightly wraps around a body part, is not rare and requires early detection to prevent serious damage.

A 23-year-old man has a benign, non-progressive hair loss patch that doesn't respond to treatment but can be cosmetically treated.

The conclusion is that three signs can help diagnose hair loss after it happens, potentially avoiding more invasive tests.

Triboelectric nanogenerators can power wearable medical devices for long-term self-treatment and monitoring.